about
Out of the active site binding pocket for carbonic anhydrase inhibitorsChalcones: a valid scaffold for monoamine oxidases inhibitorsSelective inhibitory activity against MAO and molecular modeling studies of 2-thiazolylhydrazone derivativesMonoamine oxidase isoform-dependent tautomeric influence in the recognition of 3,5-diaryl pyrazole inhibitorsSynthesis, stereochemical separation, and biological evaluation of selective inhibitors of human MAO-B: 1-(4-arylthiazol-2-yl)-2-(3-methylcyclohexylidene)hydrazinesSynthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives.The state of the art of pyrazole derivatives as monoamine oxidase inhibitors and antidepressant/anticonvulsant agents.Synthesis and biological assessment of novel 2-thiazolylhydrazones and computational analysis of their recognition by monoamine oxidase B.Recent advances in the development of selective human MAO-B inhibitors: (hetero)arylidene-(4-substituted-thiazol-2-yl)hydrazines.Evaluation of a large library of (thiazol-2-yl)hydrazones and analogues as histone acetyltransferase inhibitors: enzyme and cellular studies.Synthesis, biological evaluation and 3D-QSAR of 1,3,5-trisubstituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase A inhibitors.The thiazole derivative CPTH6 impairs autophagyPatent-related survey on new monoamine oxidase inhibitors and their therapeutic potential.Selective MAO-B inhibitors: a lesson from natural products.Synthesis of a novel series of thiazole-based histone acetyltransferase inhibitors.tert-Butylcarbamate-containing histone deacetylase inhibitors: apoptosis induction, cytodifferentiation, and antiproliferative activities in cancer cells.CPTH6, a thiazole derivative, induces histone hypoacetylation and apoptosis in human leukemia cells.Synthesis and selective human monoamine oxidase B inhibition of heterocyclic hybrids based on hydrazine and thiazole scaffolds.Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase.Synthesis, selective anti-Helicobacter pylori activity, and cytotoxicity of novel N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides.Design, synthesis and biological characterization of thiazolidin-4-one derivatives as promising inhibitors of Toxoplasma gondii.Synthesis, anti-Candida activity, and cytotoxicity of new (4-(4-iodophenyl)thiazol-2-yl)hydrazine derivatives.Investigations on the 2-thiazolylhydrazyne scaffold: synthesis and molecular modeling of selective human monoamine oxidase inhibitors.Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors.A new series of flavones, thioflavones, and flavanones as selective monoamine oxidase-B inhibitors.Inhibition of amine oxidases activity by 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives.Selective inhibition of human carbonic anhydrases by novel amide derivatives of probenecid: synthesis, biological evaluation and molecular modelling studies.Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives against monoamine oxidase.Exploring 4-substituted-2-thiazolylhydrazones from 2-, 3-, and 4-acetylpyridine as selective and reversible hMAO-B inhibitors.Enantiomers of C(5)-chiral 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives: Analytical and semipreparative HPLC separation, chiroptical properties, absolute configuration, and inhibitory activity against monoamine oxidase.Synthesis and in vitro selective anti-Helicobacter pylori activity of pyrazoline derivatives.Synthesis and evaluation of 4-acyl-2-thiazolylhydrazone derivatives for anti-Toxoplasma efficacy in vitro.Unusually high enantioselectivity in high-performance liquid chromatography using cellulose tris(4-methylbenzoate) as a chiral stationary phase.Semipreparative HPLC enantioseparation, chiroptical properties, and absolute configuration of two novel cyclooxygenase-2 inhibitors.Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins.A novel histone acetyltransferase inhibitor modulating Gcn5 network: cyclopentylidene-[4-(4'-chlorophenyl)thiazol-2-yl)hydrazone.Synthesis and selective inhibitory activity against human COX-1 of novel 1-(4-substituted-thiazol-2-yl)-3,5-di(hetero)aryl-pyrazoline derivatives.Synthesis, stereochemical identification, and selective inhibitory activity against human monoamine oxidase-B of 2-methylcyclohexylidene-(4-arylthiazol-2-yl)hydrazones.New insights into the biological properties of Crocus sativus L.: chemical modifications, human monoamine oxidases inhibition and molecular modeling studies.Synthesis of some pyrazole derivatives and preliminary investigation of their affinity binding to P-glycoprotein.
P50
Q27696192-6F50640A-B236-40E0-B62D-156CE818D4A1Q28241873-B053952A-7DCB-44E3-BBF4-2DCBCD6B67DDQ28285054-19640946-3DA3-4DD6-807C-750069D1C62EQ28285952-740C7D00-4483-41D2-B16C-52D09839F2C9Q28290729-E1595D6C-7C04-4B94-8A8E-746FC3AF4897Q34004214-5C0BB69C-8BF3-434C-AD0D-EB954572735AQ34066167-B3B7F2CF-A365-4180-9EEB-A29B9730FBC1Q34119721-E9B35AAD-3A1D-426D-8A3E-3DEC8B041F81Q34478673-DEBFE90E-94DF-466F-B412-67EB1239ABF1Q35170088-67D9739D-FBB2-4EF6-AF10-890CA6B2CDE0Q36486172-6C99B727-D101-4A79-BA75-85D07701B26CQ36733186-849BD31E-DB7F-4957-B472-AECD36B2B0FEQ38019012-49B45BED-AF37-4DBD-A8C3-A8DC6AC6C6CAQ38161850-09CA2760-30BD-43A7-BF07-2875B14712E3Q39025344-82861E0A-9F1A-4B20-83AB-6C4356C0D877Q39176128-EBFBFDE3-D98F-41BE-8F6E-F4AE673497DCQ39446176-AE032A88-F605-411C-B3DF-9369C424B8D7Q39536484-B7D67489-25E4-49EF-9130-460BB98D39B3Q39668604-A8C79769-5B8E-475A-A77E-5B8AB503D1CBQ39680280-FA192DF7-7EDB-47F6-BF27-A3DBDF09102CQ42201094-DE0F3A85-BDA6-4499-8591-46BD5CEB452FQ42718345-EB7233A8-09A4-4171-8A9E-38B100915A7BQ42975835-18646297-A2A5-4510-8A29-10155FBAC2D0Q43004937-BDCE48E1-AC48-48D1-922A-38207A783439Q43203273-DBD6FDCE-EAEC-47BE-ADCC-2EFC80A022EDQ44223601-4E1C81A3-DCBC-426D-863A-8976D73A8904Q44747022-87C68402-06ED-41C1-B63B-D5D26F9AF802Q44823674-8303CD3B-1032-407F-BB7D-9684863057E7Q45002847-E89F23BC-8A7A-4D84-94DE-00649A6DBBE5Q45070123-FA81B277-B912-4310-B3EF-51096CEB240CQ45234266-9630B51B-0EA0-4093-AD57-012CFA6C8A77Q45925066-558E9682-B555-4262-994E-CF68487EA164Q46036543-5A1B02DA-2F87-4267-9E3A-F6AEDF144172Q46075594-738D0661-C68E-474C-882E-0832B7A45576Q46097411-113C4A77-A012-426F-9629-5D580CFC5661Q46188677-B7CEC9BE-23A1-434E-B313-9A764D4657FCQ46215763-97A99F3D-AE54-4FAB-84DC-AFBB0CF5E2D4Q46455312-C9985C60-01E3-442E-825C-265A995E27CAQ46612378-98E43C79-86FF-47CC-9774-C711E2419C0FQ46649811-4F0E2529-882E-41D4-AEDB-3D7C3236B1AD
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Daniela Secci
@ast
Daniela Secci
@en
Daniela Secci
@es
Daniela Secci
@fr
Daniela Secci
@nl
Daniela Secci
@sl
type
label
Daniela Secci
@ast
Daniela Secci
@en
Daniela Secci
@es
Daniela Secci
@fr
Daniela Secci
@nl
Daniela Secci
@sl
prefLabel
Daniela Secci
@ast
Daniela Secci
@en
Daniela Secci
@es
Daniela Secci
@fr
Daniela Secci
@nl
Daniela Secci
@sl
P106
P1153
6602810282
P21
P31
P496
0000-0001-8115-026X